An Angioimmunoblastic T-cell Lymphoma Patient Presented as Persistent Hypereosinophilia With a Novel RHOA Mutation Encoding p. Ala161Glu

Lihong Cao,Hongyan Tong,Xing Liu,Yingqing Xu,Zhaoming Wang,Fang Yu,Qi Pan,Jin Lai,Wenjun Zheng,Cuihua Fan,Gongli Fu,Hao Wu,Jian Huang,Wenjuan Yu,Jie Jin

DOI: https://doi.org/10.21203/rs.3.rs-1444059/v1

2022-01-01

Abstract:Abstract Angioimmunoblastic T cell lymphoma (AITL) is a unique subtype of peripheral T cell lymphoma (PTCL). Studies have shown that RHOA p. Gly17Val mutations contribute to the specific pathogenesis of AITL. Here we reported a case of AITL with a novel RHOA mutation encoding p. Ala161Glu. This case presented with persistent hypereosinophilia for more than 3 years prior to diagnosis. At the time of diagnosis, the patient manifested with B symptoms, multiple lymphadenopathies, liver and spleen involvement. A retrospective analysis of whole exome sequencing and digital PCR of previous pathological specimens at different periods showed that RHOA p. Ala161Glu mutation and TP53 mutation occurred simultaneously. RHOA p. Ala161Glu mutation was found to be less frequent or undetectable in early gastrointestinal tract and lymph nodes. In the intestine, lymph nodes and other involved tissues, it increased with the progression of the disease. Notably, it was significantly elevated at the time of diagnosis. We presumed that the RHOA p. Ala161Glu mutation might be related to AITL pathogenesis. However, it needs further study to identify the specificity of RHOA p. Ala161Glu mutation in AITL.